Couldn't come up with anything witty to say so let's be realistic here. The only "madness of grasses" was thinking that any sales force no matter how good or bad could actually sell a drug when the entire support internally is incredibly incompetent. Every single representative, again good or bad came with extensive experience. Ask any about their prior experience with marketing, operations, sales training, payer, etc. At Greer it's not existent. Nobody in any of the support or leadership functions could work in any of their roles for any other company. Some reps are solid and some sales managers are solid like any company. But internally, it's a mess. This 5 grass...okay Oralair, never had a chance. Greer should just put all their eggs in what they are good at which is skin testing and extracts. Double or triple down there and stop Oralair completely. Don't even take on dust mite. Learn from your mistakes. SLIT will never make money in the United States, period. But to answer your question from Greer perspective, no they have not given up Oralair. Appears to be more efforts given to allergy testing in the general practice setting but Oralair is very much alive in regards to selling...even though nobody is buying. Some will say I'm a disgruntled ex-employee, but I am just realistic and anyone at Greer that disagrees is completely kidding themselves. And there is no such thing as a disgruntled ex-employee when it comes to Greer, because whether you leave on your own or are let go...the grass is absolutely greener.
